Health Care/Hospital

Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in Safety, Wellbeing and the Economy, Study Reveals

DUBAI, UAE, Aug. 19, 2026 /PRNewswire/ -- A study has estimated the Social Return on Investment (SROI) of 80Dubai Police  community initiatives at AED 647.9 million ($176.4 million), reflecting the wider social, economic and security value created for 3.8 million b...

2026-08-19 22:12 71

DrFirst Receives Frost & Sullivan's 2026 North America Enabling Technology Leadership Recognition for Advancing AI-Enhanced Medication Orchestration

DrFirst is honored for redefining medication management with its scalable platform that embeds intelligence directly in prescribing, making it more efficient for providers, pharmacies, and patients. SAN ANTONIO, Aug. 19, 2026 /PRNewswire/ -- As healthcare organizations continue to navigate fragm...

2026-08-19 21:00 180

ZEISS CLINIC 360 receives FDA 510k clearance, amplifying patient care through simplified clinical insights

The ZEISS CLINIC 360 all-in-one browser-based software solution aggregates clinical data at scale and powers advanced analytics for streamlined ophthalmic workflows, providing clinicians with more time for personalizing patient care. JENA, Germany, Aug. 19, 2026 /PRNewswire/ -- ZEISS Medical Tech...

2026-08-19 21:00 177

Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Sino Biopharmaceutical Limited (HKEX: 01177), a leading innovation-driven pharmaceutical company in China, announced the launch of its new global brand, SBP Group, during its interim results meeting. SBP stands for Science, Breakthroughs and Patients: Scie...

2026-08-19 19:45 321

Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care

Patients from Australia, India, Indonesia, South Korea and Singapore gathered at Edwards Lifesciences' annual APAC Patient Experience event to share their stories and help advance more patient-centered care. SINGAPORE, Aug. 19, 2026 /PRNewswire/ -- As structural heart disease continues to impact...

2026-08-19 17:11 607

MALAYSIA AND BANGLADESH TRANSLATE LEADERS' COMMITMENT INTO HEALTHCARE COOPERATION

Health Ministry Seeks Affordable Malaysian Healthcare for Bangladeshi Patients DHAKA, Bangladesh, Aug. 19, 2026 /PRNewswire/ -- A delegation from Malaysia Healthcare Travel Council (MHTC), led by H.E. Mohd Shuhada Othman, High Commissioner of Malaysia to Bangladesh, met with H.E. Sardar Md. Sakha...

2026-08-19 16:43 379

Strong growth from Vyepti® and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026

VALBY, Denmark, Aug. 19, 2026 /PRNewswire/ -- Key highlights Lundbeck's total revenue grew by +16% CER[1] (+11% DKK) to DKK 13,588 million in the first six months of 2026, with the U.S. and Europe delivering double-digit growth. The performance reflected continued strong commercial momentum, dr...

2026-08-19 14:48 312

Everest Medicines Announces Interim Results for First Half of 2026

SHANGHAI, Aug. 19, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced its interim results for the first hal...

2026-08-19 11:39 535

Hi & Fi Asia-China 2026 Concludes in Shanghai with Record Numbers, Handing the Baton to Hi & Fi Shenzhen This Autumn

Connecting Global Health & Food Ingredient Suppliers with Greater Bay Area Opportunities from 13–15 October 2026 at Shenzhen World SHANGHAI, Aug. 19, 2026 /PRNewswire/ -- The 27th Hi & Fi Asia-China 2026 concluded successfully in Shanghai in June, setting historic records. Centered on the theme ...

2026-08-19 10:00 717

GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma

* Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 * Blenrep, a first-in-class anti-BCMA ADC, could transform treatment as early as first relapse where additional effective treatment options are needed [...

2026-08-19 10:00 646

Ping An Good Doctor Announces 2026 Interim Results

Corporate Health Management Business Grows Steadily; AI Healthcare Empowerment Drives Continued Profitability Improvement HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its interim ...

2026-08-19 09:09 771

Antengene Presents Key R&D Highlights at the Evercore 2nd China Biotech Summit

SHANGHAI and HONG KONG, Aug. 19, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-08-19 09:00 494

GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles

Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue PISCATAWAY, N.J., Aug. 18, 2026 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548) reported first-half revenue of approximately US$404.2 million on a comparable basis, up 27....

2026-08-18 22:15 1476

Frost & Sullivan: Juno Health Receives the 2026 North American Modular EHR Delivery Customer Value Leadership Recognition for Excellence in Cloud-Native EHR Innovation

The company stands out for delivering a scalable, cloud-native platform that enhances customer experience through flexible system ownership, operational efficiency, and cost-effective EHR modernization. SAN ANTONIO, Aug. 18, 2026 /PRNewswire/ -- This week we would like to congratulateJuno Health...

2026-08-18 21:00 935

Fractal Wins US$17M+ Multi-Year AI Deal with a Fortune 500® U.S. Healthcare Organization

NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Fractal Analytics Ltd.  (BSE: 544700) (NSE: FRACTAL), a globally recognized enterprise AI company serving Fortune 500® organizations, announced that it has secured a US$17M+ multi-year agreement with a leading U.S. healthcare enterp...

2026-08-18 17:44 683

Bowtie Launches Brand-New "StillCover" Plan

Rely on Public Hospitals for Major Illnesses, Choose Private Ones for Minor Procedures Bowtie StillCover Restores the Power of Choice for Patients with "Three Highs" or Diabetes HONG KONG, Aug. 18, 2026 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[1], today announced the launch of a...

2026-08-18 15:30 657

OncoC4 Announces First Patient Dosing in Phase 1 Clinical Trial of ONC-783 for the Treatment of Advanced Solid Tumors

— ONC-783 is the first-and-only clinical-stage T-cell engager targeting a cancer-specific glycoform of CD24 (neoCD24) — — Subcutaneous formulation designed to provide gradual systemic exposure, potentially mitigating CRS risk — ROCKVILLE, Md., Aug. 17, 2026 /PRNewswire/ -- OncoC4 Inc., a late c...

2026-08-17 20:00 3133

Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia

New 316,000-square-foot facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032 PENANG, Malaysia, Aug. 17, 2026 /PRNewswire/ -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery (RAS),...

2026-08-17 14:19 2298

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

* Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages * Based on the initial arrangements, the total invoiced amount expected to be achieved by Henlius in 2026 is ...

2026-08-17 12:34 1270

New Study Confirms Capsugel® Enprotect® Capsules Deliver Robust Gastric Integrity Under Both Fasted and Fed Conditions

SEOUL, South Korea, Aug. 14, 2026 /PRNewswire/ -- Enteric capsules are widely used to protect acid-sensitive compounds and to delay drug release until intestinal entry. However, evidence supporting their gastric integrity under physiologically relevant fed-state conditions remains limited, as mos...

2026-08-17 11:45 1654
12345 ... 531